Perspective Therapeutics (CATX) Raw Materials (2011 - 2023)
Perspective Therapeutics recorded quarterly Raw Materials of $764000.0 in Q3 2023, down 2.18% quarter-over-quarter from $781000.0 in Q2 2023, and down 16.23% year-over-year from $912000.0 in Q3 2022.
Perspective Therapeutics' Raw Materials history runs 11 years deep, the most recent figure standing at $764000.0 for Q3 2023.
- In Q3 2023, Raw Materials fell 16.23% year-over-year to $764000.0; the TTM figure through Sep 2023 stood at $764000.0 (down 16.23% YoY), while the FY2022 annual figure was $752000.0, changed N/A from the prior year.
- Raw Materials came in at $764000.0 for Q3 2023 at Perspective Therapeutics, down from $781000.0 in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $912000.0 in Q3 2022 to a low of $330000.0 in Q3 2019.
- A 5-year average of $598105.3 and a median of $645000.0 in 2021 frame the typical range for Raw Materials.
- Across the five-year window, Raw Materials surged 98.69% in 2021 and dropped 16.23% in 2023, its largest moves.
- Perspective Therapeutics' Raw Materials stood at $372000.0 in 2019, then climbed by 20.43% to $448000.0 in 2020, then surged by 67.63% to $751000.0 in 2021, then increased by 0.13% to $752000.0 in 2022, then increased by 1.6% to $764000.0 in 2023.
- According to Business Quant data, Raw Materials over the past three periods registered $764000.0, $781000.0, and $777000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 764,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 752,000.00 |
| Sep 30, 2022 | 912,000.00 |
| Jun 30, 2022 | 911,000.00 |
| Mar 31, 2022 | 789,000.00 |
| Dec 31, 2021 | 751,000.00 |
| Sep 30, 2021 | 757,000.00 |
| Jun 30, 2021 | 645,000.00 |
| Mar 31, 2021 | 508,000.00 |
| Dec 31, 2020 | 448,000.00 |
| Sep 30, 2020 | 381,000.00 |
| Jun 30, 2020 | 401,000.00 |
| Mar 31, 2020 | 369,000.00 |
| Dec 31, 2019 | 372,000.00 |
| Sep 30, 2019 | 330,000.00 |
| Jun 30, 2019 | 333,000.00 |
| Mar 31, 2019 | 383,000.00 |
| Dec 31, 2018 | 379,000.00 |
| Sep 30, 2018 | 348,000.00 |
| Jun 30, 2018 | 371,000.00 |
| Mar 31, 2018 | 287,000.00 |
| Dec 31, 2017 | 367,000.00 |
| Sep 30, 2017 | 339,000.00 |
| Jun 30, 2017 | 191,000.00 |
| Jun 30, 2015 | 143,669.00 |
| Jun 30, 2014 | 173,417.00 |
| Sep 30, 2012 | 142,640.00 |
| Jun 30, 2012 | 261,835.00 |
| Jun 30, 2011 | 625,394.00 |